Cargando…

Epidemiological characteristics and adherence of a cohort of elderly people with HIV/AIDS in the Public Health System

OBJECTIVE: To characterize the epidemiological profile of patients aged 50 years or older diagnosed as HIV/AIDS, in a Specialized Service of the Public Health System. METHODS: A retrospective cohort study using secondary data from medical records in the period 2014 to 2018. Sociodemographic and clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Cristiane Marcos Soares Dias, Leite, Isabel Cristina Gonçalves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932733/
https://www.ncbi.nlm.nih.gov/pubmed/35352767
http://dx.doi.org/10.31744/einstein_journal/2022AO6474
Descripción
Sumario:OBJECTIVE: To characterize the epidemiological profile of patients aged 50 years or older diagnosed as HIV/AIDS, in a Specialized Service of the Public Health System. METHODS: A retrospective cohort study using secondary data from medical records in the period 2014 to 2018. Sociodemographic and clinical characteristics, and features related to treatment adherence were organized in a database. Quantitative variables were expressed as mean (or median) ± standard deviation (or interquartile range), and categorical variables expressed as number and percentage of patients. The Kaplan-Meier method was applied to assess the probability of overall specific survival. RESULTS: Of the 241 initially eligible patients, 149 patients were evaluated, registering 19 deaths in the studied period. There was a predominance of males aged 50-59 years, with severe immunodeficiency upon admission (29.7%), and with a CD4+ T lymphocyte count below 200 cells in 62 (46.3%) of patients. Elderly people aged 61 or over were more adherent. There was an increase in the CD4+ T lymphocyte count by an average of 139.63 in the first 6 months, and 50.51 from the first 6 months to 12 months of follow-up, with an average increase in the first 12 months of 157.63 cells. Specific overall survival in the period was 85%. CONCLUSION: Patients older than 50 years had an immune response and no viral load detection in the 12-month period, deserving further studies to improve survival.